{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:35:43Z","timestamp":1792445743189,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41401-018-0003-0","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T07:52:16Z","timestamp":1526457136000},"page":"180-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation"],"prefix":"10.1038","volume":"40","author":[{"given":"Jing-si","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-hong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/mds.23219","volume":"25","author":"IC Lopez","year":"2010","unstructured":"Lopez IC, Ruiz PJ, Del Pozo SV, Bernardos VS. Motor complications in Parkinson's disease: ten year follow-up study. Mov Disord. 2010;25:2735\u20139.","journal-title":"Mov Disord"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/pgmj.2008.075820","volume":"85","author":"K Wu","year":"2009","unstructured":"Wu K, Politis M, Piccini P. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J. 2009;85:590\u20136.","journal-title":"Postgrad Med J"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4161\/auto.21011","volume":"8","author":"B Dehay","year":"2012","unstructured":"Dehay B, Martinez-Vicente M, Ramirez A, Perier C, Klein C, Vila M, et al. Lysosomal dysfunction in Parkinson disease ATP13A2 gets into the groove. Autophagy. 2012;8:1389\u201391.","journal-title":"Autophagy"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2008.11.086","volume":"378","author":"J Park","year":"2009","unstructured":"Park J, Lee G, Chung J. The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun. 2009;378:518\u201323.","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/ars.2011.4074","volume":"16","author":"C Perier","year":"2012","unstructured":"Perier C, Bove J, Vila M. Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond. Antioxid Redox Signal. 2012;16:883\u201395.","journal-title":"Antioxid Redox Signal"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","volume":"62","author":"GD Zeevalk","year":"2008","unstructured":"Zeevalk GD, Razmpour R, Bernard LP. Glutathione Glutathione and Parkinson's disease: is this the elephant in the room? Biomed Pharmacother. 2008;62:236\u201349.","journal-title":"Biomed Pharmacother"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","volume":"39","author":"MT Islam","year":"2017","unstructured":"Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegen-erative disorders. Neurol Res. 2017;39:73\u201382.","journal-title":"Neurol Res"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/mds.10486","volume":"18","author":"PS Fitzmaurice","year":"2003","unstructured":"Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Mov Disord. 2003;18:969\u201376.","journal-title":"Mov Disord"},{"key":"3_CR9","doi-asserted-by":"publisher","unstructured":"Sun Y, Sukumaran P, Selvaraj S, Cilz NI, Schaar A, Lei S, et al. TRPM2 promotes neurotoxin MPP+\/MPTP-induced cell death. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-016-0338-9 (2016).","DOI":"10.1007\/s12035-016-0338-9"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, et al. TIGAR, a p53-inducible regulator ofglycolysis and apoptosis. Cell. 2006;126:107\u201320.","journal-title":"Cell"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/10715762.2016.1223296","volume":"50","author":"HC Yang","year":"2016","unstructured":"Yang HC, Wu YH, Liu HY, Stern A, Chiu DT. What has passed is prolog: new cellular and physiological roles of G6PD. Free Radic Res. 2016;50:1047\u201364.","journal-title":"Free Radic Res"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCRESAHA.111.246371","volume":"111","author":"JR Ussher","year":"2012","unstructured":"Ussher JR, Jaswal JS, Lopaschuk GD. Pyridine nucleotide regulation of cardiac intermediary metabolism. Circ Res. 2012;111:628\u201341.","journal-title":"Circ Res"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00425-006-0354-5","volume":"225","author":"D Marino","year":"2007","unstructured":"Marino D, Gonzalez EM, Frendo P, Puppo A, Arrese-Igor C. NADPH recycling systems in oxidative stressed pea nodules: a key role for the NADP +-dependent isocitrate dehydrogenase. Planta. 2007;225:413\u201321.","journal-title":"Planta"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10529-014-1532-3","volume":"36","author":"C Ratledge","year":"2014","unstructured":"Ratledge C. The role of malic enzyme as the provider of NADPH in oleaginous microorganisms: a reappraisal and unsolved problems. Biotechnol Lett. 2014;36:1557\u201368.","journal-title":"Biotechnol Lett"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/metabo7020022","volume":"7","author":"R Powers","year":"2017","unstructured":"Powers R, Lei S, Anandhan A, Marshall DD, Worley B, Cerny RL, et al. Metabolic investigations of the molecular mechanisms associated with Parkinson's disease. Metabolites. 2017;7:22.","journal-title":"Metabolites"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2478\/s13380-014-0221-y","volume":"5","author":"L Dunn","year":"2014","unstructured":"Dunn L, Fairfield V, Daham S, Bolaos JP, Heales SJ. Pentose-phosphate pathway disruption in the pathogenesis ofParkinson's disease. Transl Neurosci. 2014;5:179\u201384.","journal-title":"Transl Neurosci"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1523\/JNEUROSCI.4655-13.2014","volume":"34","author":"M Li","year":"2014","unstructured":"Li M, Sun M, Cao L, Gu JH, Ge J, Chen J, et al. A TIGAR-regulated metabolic pathway is critical for protection ofbrain ischemia. J Neurosci. 2014;34:7458\u201371.","journal-title":"J Neurosci"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc. 2007;2:141\u201351.","journal-title":"Nat Protoc"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/mt.2015.8","volume":"23","author":"E Cederfjall","year":"2015","unstructured":"Cederfjall E, Broom L, Kirik D. Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson's disease. Mol Ther. 2015;23:896\u2013906.","journal-title":"Mol Ther"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1523\/JNEUROSCI.12-09-03392.1992","volume":"12","author":"GD Crawford Jr.","year":"1992","unstructured":"Crawford GD Jr., Le WD, Smith RG, Xie WJ, Stefani E, Appel SH. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci. 1992;12:3392\u20138.","journal-title":"J Neurosci."},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1089\/ars.2016.6800","volume":"27","author":"M Campolo","year":"2017","unstructured":"Campolo M, Casili G, Biundo F, Crupi R, Cordaro M, Cuzzocrea S, et al. The neuroprotective effect ofdimethyl fumarate in an MPTP-mouse model of Parkinson's disease: involvement of reactive oxygen species\/ 11 nuclear factor-kappaB\/nuclear transcription factor related to NF-E2. Antioxid Redox Signal. 2017;27:453\u201371.","journal-title":"Antioxid Redox Signal"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"26096","DOI":"10.1074\/jbc.M000120200","volume":"275","author":"N Jha","year":"2000","unstructured":"Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, et al. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J Biol Chem. 2000;275:26096\u2013101.","journal-title":"J Biol Chem"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","volume":"6","author":"OI Aruoma","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593\u20137.","journal-title":"Free Radic Biol Med"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"e0157602","DOI":"10.1371\/journal.pone.0157602","volume":"11","author":"DA Monti","year":"2016","unstructured":"Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai JL, et al. N-acetyl cysteine may support dopamine neurons in Parkinson's disease: preliminary clinical and cell line data. PLoS ONE. 2016;11:e0157602.","journal-title":"PLoS ONE"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","volume":"89","author":"EK Kim","year":"2015","unstructured":"Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89:867\u201382.","journal-title":"Arch Toxicol"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","volume":"62","author":"M Smeyne","year":"2013","unstructured":"Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med. 2013;62:13\u201325.","journal-title":"Free Radic Biol Med"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"e955995","DOI":"10.1080\/23723548.2014.955995","volume":"1","author":"ND Marchenko","year":"2014","unstructured":"Marchenko ND, Moll UM. Mitochondrial death functions of p53. Mol Cell Oncol. 2014;1:e955995.","journal-title":"Mol Cell Oncol"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1523\/JNEUROSCI.4511-08.2008","volume":"28","author":"S Karunakaran","year":"2008","unstructured":"Karunakaran S, Saeed U, Mishra M, Valli RK, Joshi SD, Meka DP, et al. Selective activation ofp38 mitogen-activated protein kinase in dopaminergicneurons ofsubstantia nigra leads tonuclear translocation ofp53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. J Neurosci. 2008;28:12500\u20139.","journal-title":"J Neurosci"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.fct.2013.10.022","volume":"62","author":"C Zhang","year":"2013","unstructured":"Zhang C, Wang C, Tang S, Sun Y, Zhao D, Zhang S, et al. TNFR1\/TNF-alpha and mitochondria interrelated signaling pathway mediates quinocetone-induced apoptosis in HepG2 cells. Food Chem Toxicol. 2013;62:825\u201338.","journal-title":"Food Chem Toxicol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/STROKEAHA.115.009687","volume":"47","author":"M Li","year":"2016","unstructured":"Li M, Zhou ZP, Sun M, Cao L, Chen J, Qin YY, et al. Reduced nicotinamide adenine dinucleotide phosphate, a pentose phosphate pathway product, might be a novel drug candidate for ischemic stroke. Stroke. 2016;47:187\u201395.","journal-title":"Stroke"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2017.01.034","volume":"104","author":"YY Qin","year":"2017","unstructured":"Qin YY, Li M, Feng X, Wang J, Cao L, Shen XK, et al. Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke. Free Radic Biol Med. 2017;104:333\u201345.","journal-title":"Free Radic Biol Med"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuint.2014.09.006","volume":"80","author":"M Sun","year":"2015","unstructured":"Sun M, Li M, Huang Q, Han F, Gu JH, Xie J, et al. Ischemia\/reperfusion-induced upregulation of TIGAR in brain is mediated by SP1 and modulated by ROS and hormones involved in glucose metabolism. Neurochem Int. 2015;80:99\u2013109.","journal-title":"Neurochem Int"},{"key":"3_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep27096","volume":"6","author":"JH Zhou","year":"2016","unstructured":"Zhou JH, Zhang TT, Song DD, Xia YF, Qin ZH, Sheng R. TIGAR contributes to ischemic tolerance induced by cerebral preconditioning through scavenging of reactive oxygen species and inhibition of apoptosis. Sci Rep. 2016;6:27096.","journal-title":"Sci Rep"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0305-0491(83)90312-7","volume":"75","author":"M Suzuki","year":"1983","unstructured":"Suzuki M, O\u2019Dea JD, Suzuki T, Agar NS. 2-Deoxyglucose as a substrate for glutathione regeneration in human and ruminant red blood cells. Comp Biochem Physiol B. 1983;75:195\u20137.","journal-title":"Comp Biochem Physiol B"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/rb\/rbw032","volume":"3","author":"HJ Sun","year":"2016","unstructured":"Sun HJ, Wang Y, Hao T, Wang CY, Wang QY, Jiang XX. Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson's disease. Regen Biomater. 2016;3:299\u2013307.","journal-title":"Regen Biomater"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.mito.2009.06.001","volume":"9","author":"RK Dagda","year":"2009","unstructured":"Dagda RK, Zhu J, Chu CT. Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models. Mitochondrion. 2009;9:289\u201398.","journal-title":"Mitochondrion"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","volume":"98","author":"G Wang","year":"2012","unstructured":"Wang G, Pan J, Chen SD. Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease. Progress Neurobiol. 2012;98:207\u201321.","journal-title":"Progress Neurobiol."},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1074\/jbc.M111.294355","volume":"287","author":"J Diegelmann","year":"2012","unstructured":"Diegelmann J, Olszak T, Goke B, Blumberg RS, Brand S. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem. 2012;287:286\u201398.","journal-title":"J Biol Chem"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"792639","DOI":"10.1155\/2011\/792639","volume":"2011","author":"Y Son","year":"2011","unstructured":"Son Y, Cheong YK, Kim NH, Chung HT, Kang DG, Pae HO. Mitogen-activated protein kinases and reactive oxygen species: how can ros activate MAPK pathways? J Signal Transduct. 2011;2011:792639.","journal-title":"J Signal Transduct"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"20451","DOI":"10.1074\/jbc.M311164200","volume":"279","author":"WS Choi","year":"2004","unstructured":"Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, et al. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem. 2004;279:20451\u201360.","journal-title":"J Biol Chem"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0006-8993(00)02965-6","volume":"891","author":"WM Zawada","year":"2001","unstructured":"Zawada WM, Meintzer MK, Rao P, Marotti J, Wang X, Esplen JE, et al. Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons. Brain Res. 2001;891:185\u201396.","journal-title":"Brain Res"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/toxsci\/kfh089","volume":"79","author":"K Newhouse","year":"2004","unstructured":"Newhouse K, Hsuan SL, Chang SH, Cai B, Wang Y, Xia Z Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004;79:137\u201346.","journal-title":"Toxicol Sci."},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","volume":"20","author":"AM Sadowska","year":"2007","unstructured":"Sadowska AM, Manuel YKB, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther. 2007;20:9\u201322.","journal-title":"Pulm Pharmacol Ther"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"8715185","DOI":"10.1155\/2016\/8715185","volume":"2016","author":"X Gong","year":"2016","unstructured":"Gong X, Duan Y, Zheng J, Wang Y, Wang G, Norgren S, et al. Nephroprotective effects of N-acetylcysteine amide against contrast-induced nephropathy through upregulating thioredoxin-1, inhibiting ASK1\/p38MAPK pathway, and suppressing oxidative stress and apoptosis in rats. Oxid Med Cell Longev. 2016;2016:8715185.","journal-title":"Oxid Med Cell Longev"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12640-016-9631-7","volume":"30","author":"Z Pan","year":"2016","unstructured":"Pan Z, Niu Y, Liang Y, Zhang X, Dong M. Beta-ecdysterone protects SH-SY5Y cells against 6-hydroxydopamine-induced apoptosis via mitochondria- dependent mechanism: involvement ofp38(MAPK)-p53 signaling pathway. Neurotox Res. 2016;30:453\u201366.","journal-title":"Neurotox Res"},{"key":"3_CR46","first-page":"145","volume":"9","author":"JD Amaral","year":"2010","unstructured":"Amaral JD, Xavier JM, Steer CJ, Rodrigues CM. The role of p53 in apoptosis. Discov Med. 2010;9:145\u201352.","journal-title":"Discov Med"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bbrc.2011.06.151","volume":"411","author":"YH Kook","year":"2011","unstructured":"Kook YH, Ka M, Um M. Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP(+)) model of Parkinson's disease. Biochem Biophys Res Commun. 2011;411:370\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0831-y","volume":"14","author":"HC Kuo","year":"2016","unstructured":"Kuo HC, Lu CC, Shen CH, Tung SY, Hsieh MC, Lee KC, et al. Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. J Transl Med. 2016;14:78.","journal-title":"J Transl Med"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12035-014-8755-0","volume":"51","author":"S Wang","year":"2015","unstructured":"Wang S, He H, Chen L, Zhang W, Zhang X, Chen J. Protective effects of salidroside in the MPTP\/MPP(+)-induced model of Parkinson's disease through ROS-NO-related mitochondrion pathway. Mol Neurobiol. 2015;51:718\u201328.","journal-title":"Mol Neurobiol"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.bbabio.2006.05.032","volume":"1757","author":"E Er","year":"2006","unstructured":"Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta. 2006;1757:1301\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2014.09.010","volume":"33","author":"S Mullin","year":"2015","unstructured":"Mullin S, Schapira AH. Pathogenic mechanisms of neurodegeneration in Parkinson disease. Neurol Clin. 2015;33:1\u201317.","journal-title":"Neurol Clin"},{"key":"3_CR52","first-page":"91","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson's disease. Front Neuroanat. 2015;9:91.","journal-title":"Front Neuroanat"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1517\/14740338.2013.787065","volume":"12","author":"J Lopez-Sendon","year":"2013","unstructured":"Lopez-Sendon J, Mena MA, de Yebenes JG. Drug-induced parkinsonism. Expert Opin Drug Saf. 2013;12:487\u201396.","journal-title":"Expert Opin Drug Saf"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan BJ, Hoek S, Fon EA, Wade-Martins R. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem Sci. 2015;40:200\u201310.","journal-title":"Trends Biochem Sci"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG. Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism. Neurobiol Dis. 2013;51:35\u201342.","journal-title":"Neurobiol Dis"},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm. 1996;103:987\u20131041.","journal-title":"J Neural Transm"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","volume":"21","author":"V Viswanath","year":"2001","unstructured":"Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci. 2001;21:9519\u201328.","journal-title":"J Neurosci"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","volume":"219","author":"GE Meredith","year":"2009","unstructured":"Meredith GE, Totterdell S, Beales M, Meshul CK. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp Neurol. 2009;219:334\u201340.","journal-title":"Exp Neurol"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.intimp.2009.03.003","volume":"9","author":"I Kurkowska-Jastrzebska","year":"2009","unstructured":"Kurkowska-Jastrzebska I, Balkowiec-Iskra E, Ciesielska A, Joniec I, Cudna A, Zaremba MM, et al. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection ofthe injured nigrostriatal system in the murine MPTP model of Parkinson's disease. Int Immunopharmacol. 2009;9:781\u201391.","journal-title":"Int Immunopharmacol"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol. 2004;56:149\u201362.","journal-title":"Ann Neurol"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson's disease: an update. J Parkinsons Dis. 2011;1:19\u201333.","journal-title":"J Parkinsons Dis"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/01.WNL.0000028688.75881.12","volume":"59","author":"SM Zhang","year":"2002","unstructured":"Zhang SM, et al. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology. 2002;59:1161\u20139.","journal-title":"Neurology"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1056\/NEJM199301213280305","volume":"328","author":"Parkinson Study G","year":"1993","unstructured":"Parkinson Study G. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson\u2019s disease. New Engl J Med. 1993;328:176\u201383.","journal-title":"New Engl J Med."},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"CW Shults","year":"2002","unstructured":"Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59:1541\u201350.","journal-title":"Arch Neurol"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24:325\u201340.","journal-title":"Exp Neurobiol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0003-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0003-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0003-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:00:47Z","timestamp":1684616447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0003-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0003-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"25 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}